Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Jan-07 5:07 PM View:  | Chowrira Bharat M VP Legal Affairs | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 10,245 | -- | -- | (100%) 10.24K to 0 | |
| 04-Jan-07 5:09 PM View: | French J Michael Sr. VP, Corporate Development | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 8,201 | -- | -- | (100%) 8.2K to 0 | |
| 03-Jan-07 10:35 AM View: | Roberts Bryan E Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 5,048,620 | $13.00 | $65,632,000.00 | (100%) 5.05M to 0 | |
| 04-Jan-07 5:09 PM View: | Greer R Scott Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 106,596 | -- | -- | (100%) 106.6K to 0 | |
| 04-Jan-07 5:10 PM View: | Robin Howard W CEO & President Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition Duplicate | 22,125 | -- | -- | (96%) 22.96K to 0.83K | |
| 04-Jan-07 5:10 PM View: | Polisky Barry Senior VP Research & CSO | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 5,044 | -- | -- | (100%) 5.04K to 0 | |
| 09-Jan-07 8:11 PM View: | Niedel James Director 10% Owner | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 381,336 | -- | -- | (100%) 381.34K to 0 | |
| 04-Jan-07 5:10 PM View: | Weaver Gregory L Senior Vice President and CFO | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 15,000 | -- | -- | (100%) 15.0K to 0 | |
| 04-Jan-07 5:10 PM View: | Lingnau Lutz Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 2,000 | -- | -- | (100%) 2.0K to 0 | |
| 04-Jan-07 5:10 PM View: | Robin Howard W CEO & President Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 22,125 | -- | -- | (96%) 22.96K to 0.83K | |
| 04-Jan-07 5:10 PM View: | Robin Howard W CEO & President Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition Duplicate | 833 | -- | -- | (100%) 0.83K to 0 | |
| 04-Jan-07 5:09 PM View: | Guerciolini Roberto Senior VP Development & CMO | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 32,193 | -- | -- | (100%) 32.19K to 0 | |
| 03-Jan-07 10:35 AM View: | Roberts Bryan E Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 232 | $13.00 | $3,016.00 | (< 1%) 5.05M to 5.05M | |
| 04-Jan-07 5:10 PM View: | Robin Howard W CEO & President Director | Sirna Therapeutics Inc (RNAI) | 29-Dec-06 | Disposition | 833 | -- | -- | (100%) 0.83K to 0 | |
| 25-May-06 7:24 PM View: | Weaver Gregory L Senior Vice President and CFO | Sirna Therapeutics Inc (RNAI) | 25-May-06 | Market Purchase | 15,000 | $5.06 | $75,900.00 | 100% 0 to 15.0K | |
| 23-Feb-06 8:52 PM View: | Polisky Barry Sr. Vice President, Research | Sirna Therapeutics Inc (RNAI) | 21-Feb-06 | Grant | 7,509 | -- | -- | 2248% 0.33K to 7.84K | |
| 23-Feb-06 8:54 PM View: | Chowrira Bharat M VP Legal, Lic & Patent Counsel | Sirna Therapeutics Inc (RNAI) | 21-Feb-06 | Grant | 7,411 | -- | -- | 123% 6.0K to 13.41K | |
| 23-Feb-06 8:51 PM View: | Robin Howard W President & CEO Director | Sirna Therapeutics Inc (RNAI) | 21-Feb-06 | Grant | 13,833 | -- | -- | 101% 13.66K to 27.49K | |
| 23-Feb-06 8:53 PM View: | French J Michael Sr. VP, Corporate Development | Sirna Therapeutics Inc (RNAI) | 21-Feb-06 | Grant | 8,201 | -- | -- | 100% 0 to 8.2K | |
| 23-Feb-06 8:53 PM View: | Guerciolini Roberto Chief Med Off & Sr. VP of Dev. | Sirna Therapeutics Inc (RNAI) | 21-Feb-06 | Grant | 9,683 | -- | -- | 58% 16.7K to 26.38K | |
| 09-Sep-05 2:22 PM View: | Venrock Associates III Lp 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Disposition (other) | 1,999,980 | -- | -- | (33%) 6.04M to 4.04M | |
| 09-Sep-05 2:34 PM View: | Roberts Bryan E Director 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Acquisition (other) | 232 | -- | -- | < 1% 5.05M to 5.05M | |
| 09-Sep-05 2:30 PM View: | Venrock Entrepreneurs Fund ... 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Disposition (other) | 49,964 | -- | -- | (33%) 150.97K to 101.0K | |
| 09-Sep-05 2:33 PM View: | Vef Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Acquisition (other) | 546 | -- | -- | < 1% 101.0K to 101.55K | |
| 09-Sep-05 2:33 PM View: | Vef Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Disposition (other) | 544 | -- | -- | (< 1%) 101.55K to 101.01K | |
| 09-Sep-05 2:28 PM View: | Venrock Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Acquisition (other) | 10,016 | -- | -- | < 1% 4.04M to 4.05M | |
| 09-Sep-05 2:28 PM View: | Venrock Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Disposition (other) | 10,011 | -- | -- | (< 1%) 4.05M to 4.04M | |
| 09-Sep-05 2:20 PM View: | Venrock Associates 10% Owner | Sirna Therapeutics Inc (RNAI) | 07-Sep-05 | Disposition (other) | 449,948 | -- | -- | (33%) 1.36M to 908.78K | |
| 08-Jul-05 7:06 PM View: | Greer R Scott Director | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 37,500 | $1.60 | $60,000.00 | 54% 69.1K to 106.6K | |
| 08-Jul-05 4:51 PM View: | Oxford Bioscience Partners ... 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 12,418 | $1.60 | $19,868.80 | < 1% 5.85M to 5.87M | |
| 08-Jul-05 11:04 AM View: | Venrock Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase Duplicate | 1,000,000 | $1.60 | $1,600,000.00 | 20% 5.04M to 6.04M | |
| 08-Jul-05 4:40 PM View: | Niedel James Director 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 3,046,880 | $1.60 | $4,875,000.00 | 25% 12.21M to 15.25M | |
| 08-Jul-05 5:47 PM View: | Credit Suisse First Boston/ 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase Duplicate | 3,046,880 | $1.60 | $4,875,000.00 | 26% 11.83M to 14.87M | |
| 08-Jul-05 10:59 AM View: | Venrock Associates 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 225,000 | $1.60 | $360,000.00 | 20% 1.13M to 1.36M | |
| 08-Jul-05 11:01 AM View: | Venrock Associates III Lp 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 1,000,000 | $1.60 | $1,600,000.00 | 20% 5.04M to 6.04M | |
| 08-Jul-05 11:07 AM View: | Roberts Bryan E Director 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 1,250,000 | $1.60 | $2,000,000.00 | 20% 6.3M to 7.55M | |
| 08-Jul-05 11:02 AM View: | Venrock Entrepreneurs Fund ... 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 24,999 | $1.60 | $39,998.40 | 20% 125.97K to 150.97K | |
| 08-Jul-05 4:51 PM View: | Oxford Bioscience Partners ... 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 1,237,580 | $1.60 | $1,980,130.00 | 27% 4.62M to 5.85M | |
| 08-Jul-05 11:06 AM View: | Vef Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase Duplicate | 24,999 | $1.60 | $39,998.40 | 20% 125.97K to 150.97K | |
| 08-Jul-05 4:40 PM View: | Niedel James Director 10% Owner | Sirna Therapeutics Inc (RNAI) | 06-Jul-05 | Market Purchase | 78,126 | $1.60 | $125,002.00 | < 1% 12.13M to 12.21M | |
| 04-Jan-05 7:04 PM View: | Oxford Bioscience Partners ... 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) Duplicate | 8,130 | $2.52 | $20,487.60 | < 1% 4.61M to 4.62M | |
| 04-Jan-05 9:56 PM View: | Niedel James Director | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 25,519 | $2.52 | $64,307.90 | < 1% 11.52M to 11.54M | |
| 04-Jan-05 2:44 PM View: | Vef Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) Duplicate | 21,593 | $2.52 | $54,414.40 | 21% 104.38K to 125.97K | |
| 04-Jan-05 9:56 PM View: | Niedel James Director | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 14,910 | $2.52 | $37,573.20 | < 1% 11.54M to 11.56M | |
| 04-Jan-05 2:41 PM View: | Venrock Management III LLC 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) Duplicate | 863,721 | $2.52 | $2,176,580.00 | 21% 4.18M to 5.04M | |
| 04-Jan-05 7:08 PM View: | Mrna Fund II Lp 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 8,130 | $2.52 | $20,487.60 | < 1% 3.8M to 3.81M | |
| 04-Jan-05 9:56 PM View: | Credit Suisse First Boston/ 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 596,418 | $2.52 | $1,502,970.00 | 5% 11.52M to 12.11M | |
| 04-Jan-05 7:04 PM View: | Oxford Bioscience Partners ... 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 810,315 | $2.52 | $2,041,990.00 | 21% 3.8M to 4.61M | |
| 04-Jan-05 2:37 PM View: | Venrock Associates 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 194,337 | $2.52 | $489,729.00 | 21% 939.39K to 1.13M | |
| 04-Jan-05 2:39 PM View: | Venrock Associates III Lp 10% Owner | Sirna Therapeutics Inc (RNAI) | 30-Dec-04 | Exercise (in-the money or at-the-money) | 863,721 | $2.52 | $2,176,580.00 | 21% 4.18M to 5.04M |
